Tomasz Wirt

Tomasz is a biotechnology expert with a rich background in nucleic acid-based technologies and personalized medicine, bringing academic experience and start-up innovation to his role at Potter Clarkson.

Tomasz's academic focus was developing innovative techniques to address the needs of the life sciences sector. He has deep understanding in biotechnology and molecular biology, particularly in nucleic acid applications for molecular diagnostics, imaging, and high-throughput omics research.

As part of his studies, Tomasz undertook a secondment at the University of Massachusetts Medical School, where together with Nobel Laureate Professor Victor Ambros Tomasz merged his skills in molecular imaging with developmental biology and RNA silencing. He has authored numerous scientific publications and is a co-inventor on two patent applications.

Beyond academia, Tomasz has worked in two Stockholm-based start-ups, coordinating research teams to develop diagnostic devices and personalised medicine methods. Before joining Potter Clarkson in 2021, Tomasz led the development of a novel RNA-sequencing-based drug screening platform at SciLifeLab, Stockholm.